QUOTE AND NEWS
Benzinga  Jan 23  Comment 
Novogen Limited (NASDAQ: NVGN) - In addition to the listing of its ordinary shares on the Australian Stock Exchange, the Company has an American Depository Receipt program with the ADRs listed on the Nasdaq Capital Market. The Company had...
Benzinga  Dec 29  Comment 
View filing here. View tweet here. (c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
The Australian  Nov 6  Comment 
NOVOGEN chairman William Rueckert has no intention of privatising the biotechnology company.
Benzinga  Aug 16  Comment 
Shares of Marshall Edwards (NASDAQ: MSHL) are screaming higher this morning on word that its Investigational New Drug application for ME-143, the Company's lead NADH oxidase inhibitor, has been approved by the FDA. Currently, shares are higher...
StreetInsider.com  Apr 5  Comment 
National Semi (NYSE: NSM) 71.4% HIGHER; Texas Instruments to buy National Semi for $25/share in cash. The stock was upgraded at Citi and Citadel and downgraded at Miller Tabak and Susquehanna. Novogen (Nasdaq: NVGN) 34.4% HIGHER; traders are...
Penny Stock DD  Mar 29  Comment 
Novogen Limited (ADR) (NASDAQ:NVGN) surged by 104.72% and closed at $2.17 whereas overall traded volume stood at 5.40 million shares for the day. The current market price is 147.89% more than its last 50 days simple moving average. The RSI value...
StreetInsider.com  Mar 28  Comment 
Novogen (Nasdaq: NVGN) 119.8% HIGHER; shares have rallied extremely sharply this morning however we are not hearing any company-specific news. Volume today is better then ten-times the trailing three-month daily average. Ocean Bio-Chem Inc....
Penny Stock DD  Jan 25  Comment 
Clinical Data, Inc. (NASDAQ:CLDA) surged by 67.47% to close at $25.17 with overall traded volume of 15.60 million shares in the last trading day. Its outstanding share stood at 29.96 million. Its total market capitalization stood at $754.09...
Penny Stock DD  Jan 24  Comment 
NVGN NOVOGEN LTD-ADR business is in the area of medicine know as degenerative diseases and disorders. Novogen is addressing this urgent area of medical need through the Novogen isoflavonoid technology platform - a platform that the Company...
Marketwire  Sep 20  Comment 
SYDNEY, AUSTRALIA -- (Marketwire) -- 09/20/10 -- Pharmaceutical development company, Novogen Limited (ASX: NRT) (NASDAQ: NVGN) has appointed three new Directors. Of the three Directors, two are based in the United States and one in Australia, with





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki